First Spherical Nucleic Acid Drug Injected Into Humans Targets Brain Cancer
Science & Technology Research News
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme. A clinical trial has just been launched at the Robert... Read the full story
Shared from Apple News
_- Steve
No comments:
Post a Comment